No Photo Available

Last Update

2016-06-27T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Diane Young?

Dr. Diane C. Young

Vice President for Clinical Development

Novartis AG

Direct Phone: (862) ***-****       

Email: d***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Novartis AG

Lichtstrasse 35

Basel, 4056

Switzerland

Company Description

Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets innovative medicines aimed at improving patients' lives. We offer a broad range of medicines for cancer, cardiovascular disease, endocrine disease, inflammatory disease, i ... more

Find other employees at this company (62,769)

Background Information

Employment History

Vice President, Global Clinical Development

Johnson and Johnson

Contributor

PR Newswire

Affiliations

Board of Trustees Member
The Valerie Fund

Board Member
The Valerie Fund

Education

MD

Web References (198 Total References)


Board of Trustees

www.thevaleriefund.org [cached]

Diane Young, M.D. - Novartis Click here to read biography Diane Young, M.D., Novartis Diane is currently the Vice President of Clinical Development at Novartis Oncology. In this position, she leads a global group of clinical research personnel and oversees the development of a diverse pipeline of oncology and hematology products, including targeted therapies, cytotoxic chemotherapy, and iron chelation therapy. She has pursued her career in research in the pharmaceutical industry for eighteen years, with positions of increasing responsibility at Hoffman-La Roche, Sandoz, and Johnson and Johnson, prior to joining Novartis.


The Valerie Fund Board of Trustees

www.thevaleriefund.org [cached]

Diane Young, M.D. - Novartis

...
Diane Young, M.D.
...
Diane Young, M.D., Novartis Diane is currently the Vice President of Clinical Development at Novartis Oncology. In this position, she leads a global group of clinical research personnel and oversees the development of a diverse pipeline of oncology and hematology products, including targeted therapies, cytotoxic chemotherapy, and iron chelation therapy. She has pursued her career in research in the pharmaceutical industry for eighteen years, with positions of increasing responsibility at Hoffman-La Roche, Sandoz, and Johnson and Johnson, prior to joining Novartis.


Board of Trustees - The Valerie Fund

www.thevaleriefund.org [cached]

Diane Young, M.D., Novartis

...
Diane Young, M.D., Novartis Diane Young is currently the Vice President of Clinical Development at Novartis Oncology. In this position, she oversees the development of a diverse pipeline of oncology and hematology products, including targeted therapies, cytotoxic chemotherapy, iron chelation therapy, and others. She leads a global group of clinical research personnel. She has pursued her career in research in the pharmaceutical industry for eighteen years, with positions of increasing responsibility at Hoffman-La Roche, Sandoz, and Johnson and Johnson, prior to joining Novartis.


Positive results prompt US National Cancer Institute to make Gleevec available to patients in post-surgical GIST study – Gistinfo.org

www.gistinfo.org [cached]

With these new data, we see that Gleevec may help patients with early GIST, said Diane Young, MD, Head of Global Medical Affairs at Novartis Oncology.


Dr. Diane C. Young is the ...

www.memphisdailynews.com [cached]

Dr. Diane C. Young is the new vice president, chief medical officer, of Learn more about GTx Inc

...
Young is an oncologist with 25 years of clinical development experience in the industry, most recently at Novartis, where she spent 12 years in global and regional leadership roles in oncology clinical development and medical affairs. She also spent a decade at Johnson and Johnson, serving as vice president of global development at R.W. Johnson Pharmaceutical Research Institute.
In her new role, Young will help oversee the clinical development of GTx's product candidates, including its selective androgen receptor modulator, enobosarm.

Similar Profiles

Other People with this Name

Other people with the name Young

Joe Young
Compass Housing Services Co Ltd

Hamish Young
The University of Melbourne

Charlotte Young
Morley-Parren-Bright Agency

Daniel Young
Tincture Journal

Thomas Young
Lumos & Associates , Inc.

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory